Literature DB >> 10871846

Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis.

K Ise1, K Nakamura, K Nakao, S Shimizu, H Harada, T Ichise, J Miyoshi, Y Gondo, T Ishikawa, A Aiba, M Katsuki.   

Abstract

To clarify the role of the H-Ras in vivo, we generated H-ras null mutant mice by gene targeting. In spite of the importance of the Ras in cell proliferation and differentiation, H-ras null mutant mice grew normally and were fertile. The oldest H-ras mutant mice grew to be more than 30 months old. We used the H-ras deficient mice to study the importance of the H-ras and other ras genes in the development of skin tumors induced by initiation with 7, 12-dimethylbenz(a)anthracene (DMBA) followed by promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA). We showed that H-ras null mutant mice develop approximately six times less papillomas compared with wild-type littermates after 20 weeks of TPA treatment. While all papillomas examined (17 out of 17) in wild-type mice have mutations of H-ras at codon 61, 13 (62%) out of 21 papillomas in H-ras null mutant mice have mutations of K-ras gene at codon 12, 13, or 61 and another eight (38%) papillomas have no mutations in these codons of K-ras or N-ras genes. This suggests that the activation of H-ras gene is critical in the wild-type mice, but the activation of K-ras gene can replace the H-ras activation in the initiation step of skin tumor development in the H-ras deficient mice. Oncogene (2000).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871846     DOI: 10.1038/sj.onc.1203600

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  54 in total

Review 1.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

Review 2.  Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.

Authors:  Gustavo Baldassarre; Barbara Belletti
Journal:  Small GTPases       Date:  2016-04-08

3.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

Review 4.  Minireview: physiological and pathological actions of RAS in the ovary.

Authors:  Heng-Yu Fan; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2009-10-30

5.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

6.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

7.  Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis.

Authors:  Iris Helfrich; Min Chen; Rainer Schmidt; Gerhard Fürstenberger; Annette Kopp-Schneider; David Trick; Hermann-Josef Gröne; Harald Zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Rb and N-ras function together to control differentiation in the mouse.

Authors:  Chiaki Takahashi; Roderick T Bronson; Merav Socolovsky; Bernardo Contreras; Kwang Youl Lee; Tyler Jacks; Makoto Noda; Raju Kucherlapati; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.

Authors:  Mandayam O Nandan; Amr M Ghaleb; Beth B McConnell; Nilesh V Patel; Sylvie Robine; Vincent W Yang
Journal:  Mol Cancer       Date:  2010-03-18       Impact factor: 27.401

Review 10.  Phospholipase signalling networks in cancer.

Authors:  Jong Bae Park; Chang Sup Lee; Jin-Hyeok Jang; Jaewang Ghim; Youn-Jae Kim; Sungyoung You; Daehee Hwang; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.